Analysing the Effect of Empagliflozin on Reduction of Tissue Sodium Content in Patients With Chronic Heart Failure
NCT03128528
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
84
Enrollment
OTHER
Sponsor class
Conditions
Chronic Heart Failure
Interventions
DRUG:
Empagliflozin 10mg
DRUG:
Placebo Oral Tablet
Sponsor
University of Erlangen-Nürnberg Medical School